Our study examines how RNA in extracellular vesicles (EVs) can provide insights into metabolic phenotypes related to obesity.

Emeli Chatterjee, Ph.D., of the Cardiovascular Research Center at Massachusetts General Hospital, is the lead author and ...

Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.

Discover how Adipotide, a promising peptide, could revolutionise our understanding of adipose tissue dynamics and metabolic regulation, paving the way for innovative therapies.

Researchers have mapped human fat tissue at single-cell resolution, uncovering how obesity alters cellular stress, ...

This discovery not only unveils a novel mechanism by which BAT influences liver metabolism but also highlights miR-206-3p as a potential therapeutic ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

Pennington Biomedical researchers have contributed to a study highlighting the crucial role of cysteine in regulating ...

Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...